R. Van Heeswijk

13 SIMILAR SVR RATES IN IL28B CC, CT OR TT PRIOR RELAPSER PARTIAL- OR NULL-RESPONDER PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN: RETROSPECTIVE ANALYSIS OF THE REALIZE STUDY

Stanislas Pol, Jeroen Aerssens, Stefan Zeuzem et al. · Journal of Hepatology · 2011 · 71 citations

Pharmacy, Internal Medicine, Pharmacotherapy +12

Gonad development and spawning behaviour of artificially-matured European eel (Anguilla anguilla L.)

Vincent van Ginneken, Gerjanne Vianen, Bie Muusze et al. · Animal Biology · 2005 · 52 citations

Life Sciences, Animal Sciences, Endocrinology +14

5 REALIZE TRIAL FINAL RESULTS: TELAPREVIR-BASED REGIMEN FOR GENOTYPE 1 HEPATITIS C VIRUS INFECTION IN PATIENTS WITH PRIOR NULL RESPONSE, PARTIAL RESPONSE OR RELAPSE TO PEGINTERFERON/RIBAVIRIN

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · Journal of Hepatology · 2011 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

6 SUBANALYSES OF THE TELAPREVIR LEAD-IN ARM IN THE REALIZE STUDY: RESPONSE AT WEEK 4 IS NOT A SUBSTITUTE FOR PRIOR NULL RESPONSE CATEGORIZATION

Graham R. Foster, Stefan Zeuzem, Pietro Andreoné et al. · Journal of Hepatology · 2011 · 27 citations · Full text

Medicine, Biostatistics, Pharmacology +3

T-27 Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study

Pietro Andreoné, Stanislas Pol, Stuart K. Roberts et al. · Digestive and Liver Disease · 2012 · 24 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17